Not applicableStudy completedNCT02896946What this trial is testingDiffusion MRI for Pancreatic AdenocarcinomaWho this might be right forPancreatic Adenocarcinoma Hospices Civils de Lyon 118
Early research (Phase 1)Study completedNCT00467116What this trial is testingPhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas CaWho this might be right forPancreatic Cancer Vanderbilt-Ingram Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT01144455What this trial is testingStudy of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic AdenocarcinomaWho this might be right forPancreatic Adenocarcinoma ImmunoGenesis 214
Testing effectiveness (Phase 2)Study completedNCT02806648What this trial is testingA Trial to Assess the Activity and Safety of Palbociclib in Patients With Well and Moderately Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)Who this might be right forPancreatic Neuroendocrine Cancer Grupo Espanol de Tumores Neuroendocrinos 21
Testing effectiveness (Phase 2)Study completedNCT00335543What this trial is testingGemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By SurgeryWho this might be right forPancreatic Cancer Interdisziplinare Arbeitsgruppe Gastrointestinaler Tumore der Deutschen Krebsgesellschaft 254
Testing effectiveness (Phase 2)Study completedNCT00290693What this trial is testingCapecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer University of Miami 45
Testing effectiveness (Phase 2)Ended earlyNCT00967291What this trial is testingMitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer IRCCS San Raffaele 21
Testing effectiveness (Phase 2)WithdrawnNCT00253526What this trial is testingGemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic CancerWho this might be right forAdenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00002689What this trial is testingRadiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic CancerWho this might be right forPancreatic Cancer Center for Molecular Medicine 48
Testing effectiveness (Phase 2)Study completedNCT05361668What this trial is testingStudy to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid SyndromeWho this might be right forCarcinoid SyndromeCarcinoidCarcinoid Tumor+6 more Crinetics Pharmaceuticals Inc. 36
Testing effectiveness (Phase 2)Temporarily pausedNCT05494697What this trial is testingAmpligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPCWho this might be right forPancreatic Cancer AIM ImmunoTech Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT06659705What this trial is testingCutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)Who this might be right forPancreatic Ductal Adenocarcinoma (PDAC) Institut Curie 35
Early research (Phase 1)Study completedNCT04580485What this trial is testingINCB106385 Alone or in Combination With Immunotherapy in Advanced Solid TumorsWho this might be right forOvarian CancerBladder CancerNon Small Cell Lung Cancer+8 more Incyte Corporation 54
Not applicableUnknownNCT05957250What this trial is testing[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct CancerWho this might be right forPancreatic CancerCholangiocarcinoma Amsterdam UMC, location VUmc 63
Testing effectiveness (Phase 2)UnknownNCT05047991What this trial is testingStudy of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic Cancer Non-resectablePancreatic Cancer Metastatic CSPC Ouyi Pharmaceutical Co., Ltd. 153
Testing effectiveness (Phase 2)Study completedNCT04669197What this trial is testingStudy of Paclitaxel Protein Bound + Gemcitabine + Cisplatin + Hydroxychloroquine as Treatment in Untreated Pancreas CancerWho this might be right forUntreated Resectable Pancreatic AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma HonorHealth Research Institute 19
Testing effectiveness (Phase 2)Looking for participantsNCT07629960What this trial is testingA First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS MutationsWho this might be right forAdvanced Solid TumorNon-Small Cell Lung CancerColorectal Neoplasms+1 more Blueprint Medicines Corporation 265
Testing effectiveness (Phase 2)Looking for participantsNCT04570943What this trial is testingSequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic CancerWho this might be right forLocally Advanced Pancreatic Adenocarcinoma Institut du Cancer de Montpellier - Val d'Aurelle 103
Large-scale testing (Phase 3)Study completedNCT00033735What this trial is testingIrofulven Compared With Fluorouracil in Treating Patients With Pancreatic CancerWho this might be right forPancreatic Cancer Eisai Inc. 158
Testing effectiveness (Phase 2)Study completedNCT00837876What this trial is testingSorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryWho this might be right forPancreatic Cancer Vanderbilt-Ingram Cancer Center 37